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Intestinal Involvement in Kawasaki Disease
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Objectives To describe a case of Kawasaki disease with intestinal involvement and to analyze other published
reports to define clinical characteristics, diagnostic issues, and therapeutic approaches of gastrointestinal involve-
ment in Kawasaki disease.
Study design A computerized search without language restriction was conducted using PubMed and SCOPUS.
An article was considered eligible for inclusion in the systematic review if it reported data on patient(s) with intes-
tinal involvement in Kawasaki disease. Our case was also included in the analysis.
Results Thirty-three articles reporting 48 cases of Kawasaki disease with intestinal involvement were consid-
ered. Fever, abdominal pain, and vomiting were the most frequent symptoms observed and typical Kawasaki disease
signs and symptoms appeared after intestinal complaints in all cases. Plain radiographs, ultrasonography, and com-
puted tomography showed pseudo-obstruction as the most frequent sign of gastrointestinal involvement; 25 pa-
tients underwent surgery. Cardiac involvement was documented in 21 cases. All but three patients received medical
treatment with immunoglobulin intravenous or aspirin. The outcome was good in 28 patients; 7 patients showed
persistence of coronary artery abnormalities; 1 patient developed cyanosis, and later, left hand and forefoot gan-
grene; 3 patients died.
Conclusions The diagnosis and treatment of Kawasaki disease might be delayed if intestinal symptoms appear
before the characteristic clinical features of Kawasaki disease, thus, increasing the risk of cardiac complications.
Furthermore, patients may undergo unnecessary invasive procedures. Pediatricians and pediatric surgeons, there-
fore, should consider Kawasaki disease among diagnoses in children with fever, abdominal symptoms, and radio-
logic findings of pseudo-obstruction. (J Pediatr 2018;202:186-93).
K awasaki disease is a vasculitis of unknown origin of small and medium caliber blood vessels, especiallyinvolving coronary arteries. Coronary artery abnormalities (CAAs) occur approximately in 25% of untreatedpatients.1
In developed countries, Kawasaki disease represents the leading cause of acquired heart disease in childhood. It mainly affects
children under 5 years of age and has a male:female of 1.5-1.7:1. Diagnosis is based on the presence of fever (lasting >5 days)
and of 4 of the 5 classic diagnostic criteria (oropharyngeal changes, bilateral bulbar conjunctival injection without exudate,
rash, change of the extremities, cervical lymphadenopathy ≥1.5 cm diameter). However, diagnosis can be made with incom-
plete features if fewer than 4 of the above-mentioned criteria are present.1
Severe intestinal involvement is a rare complication of Kawasaki disease, even if vomiting and diarrhea are frequently re-
ported symptoms. Little is known collectively about the disease background, course, clinical characteristics, diagnostic issues,
and short-/long-term therapeutic approaches in patients with intestinal involvement.
We report a case of Kawasaki disease with intestinal involvement and analyzed the medical literature to report the epide-
miologic and clinical characteristics of cases of Kawasaki disease with intestinal involvement.
Methods
A computerized search was performed without language restriction using PubMed and Scopus, combining the terms “Kawasaki
AND (intestinal or bowel)” with no filters. Furthermore, all references listed were hand-searched for other relevant articles, and
a citation tracker was used to identify any other relevant literature. An article was
considered eligible for inclusion if it reported cases with full clinical data consis-
tent with intestinal involvement and Kawasaki disease diagnostic criteria. The fol-
lowing epidemiologic and clinical variables were evaluated for each case: sex, age,
symptoms, cardiac and intestinal involvement, surgical procedures (laparotomy,
CAAs Coronary artery abnormalities
CT Computed tomography
IGIV Immunoglobulin intravenous
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resection, colostomy), type of treatment, and outcome. Cardiac
involvement was defined by the echocardiography-documented
presence of pericardial effusion or CAAs or both. Obstruction
and pseudo-obstruction characterized gastrointestinal involve-
ment, with presence of abdominal pain or distension as well
as the radiographic presence of dilated loops of bowel, gas
and/or fluid level in the intestinal lumen, or wall stenosis.
Outcome was considered good in patients responding to
treatment and not presenting with sequelae.
Results
Our search retrieved 38 papers,2-39 5 of which were excluded
from analysis because clinical and laboratory data were not
complete.35-39 Thirty-three articles reporting 48 cases of Ka-
wasaki disease with intestinal involvement were included, dating
from 1979 to 2017. Most articles are single case reports, two
are case series of 310 and 219 children with Kawasaki disease,
in which 7 and 10 cases with gastrointestinal involvement,
respectively, were reported.5,15 Data regarding the clinical
and radiologic characteristics, therapy, and outcome of all
patients (including the case from our clinical practice) are de-
scribed in Table I. Clinical features are summarized in Table II.
The mean age of the patients was 39.5 months (SD ±31,1) and
median age was 36 months (IQR 3-54 months). In 10 cases,
age was not available.
Fever, abdominal pain, and vomiting were the most fre-
quently observed symptoms at Kawasaki disease onset in
40 (82%), 34 (69%), and 24 (49%) cases, respectively. Diarrhea
and jaundice were present in 14 (29%) and 1 (2%) case, re-
spectively. Other Kawasaki disease signs and symptoms always
appeared after the intestinal ones, although in 14 cases (29%)
Kawasaki disease diagnosis was incomplete because only
abdominal symptoms were present. Plain radiograph, ultra-
sonography, and computed tomography (CT) showed pseudo-
obstruction as the most frequent sign of gastrointestinal
involvement (multiple dilated intestinal loops with multiple
fluid and gas levels and/or concentric thickening of the intes-
tinal wall) in 38 cases (77%).2-6,8,9,12-17,19-23,27-33 However, pseudo-
obstruction was accompanied by ischemic colitis in 1 case
(2%),4 hydrops of the gallbladder in 1 case (2%),6 mesenteric
and splenic ischemia28 in 1 case (2%), hemorrhagic duodenitis15
in 2 cases (4%), and appendicular involvement in 10 cases
(20%).15,21,25,27,28 Only 1 case showed mechanical obstruction
with intussusception,24 and 1 patient whose radiograph showed
presence of free subdiaphragmatic intraperitoneal air devel-
oped a perforated ulcer in the descending duodenum.29 Re-
garding surgical procedures, 25 (51%) patients underwent
surgery, 5 (10%) underwent exploratory laparotomy,2,8,15,29,30
8 (16%) required resection of the restricted loop and tempo-
rary colostomy,3,6,9,12,14,23,28,32 and 1 (2%) required enterolysis.4
Endoscopy for hematemesis was performed in 2 cases (4%).15,29
Cardiac involvement was documented in 21 (43%) of the
cases considered.3-6,9,12-16,20-23,27,28,31,32
All patients except 32,3 received medical treatment: 12 patients
(25%) were administered immunoglobulin intravenous (IGIV)
alone, and 18 patients (37%) were administered IGIV with
aspirin.2,5,13,16,17,20-22,24,33
The outcome was good in 28 patients (57%, includ-
ing the 3 patients who did not receive medical
treatment).4,6,12,17,19,21-24,27,29-34 Seven patients (14%) showed
persistence of CAAs,5,15,16,20,21 and 1 (2%) patient developed
cyanosis, and later, left hand and forefoot gangrene.3 Three
patients (6%) died: in 1 case autopsy revealed massive liver
necrosis and progressive duodenal infarction with systemic
arteritis and periarteritis involving vessels of all sizes3; the
second patient died 2 days after the exploratory laparotomy2;
the third patient died because of Pseudomonas septic
shock.18
One patient presented with a recurrence 3 years later.15 No
gastrointestinal sequelae were reported in survivors, al-
though duration of follow-up was variable, or not reported.
Case Report
A 14-year-old boy admitted to our Infectious Disease Depart-
ment for high fever (39°C) and abdominal pain of 2 days’ du-
ration. Upon admission, he had conjunctival and pharyngeal
hyperemia, as well as cervical lymphadenopathy ≥1.5 cm in
diameter. Blood tests revealed white blood cell 9.090/uL,
(neutrophils 8500/uL lymphocytes 290/uL, platelets 196 000),
serum transaminases (aspartate aminotransferase 24 U/L,
alanine aminotransferase 40 U/L), hemoglobin 13.8 mg/dL, and
C-reactive protein 177 mg/L. Abdominal CT performed on the
day of hospitalization showed hepatosplenomegaly and
fluid in the pelvic and mesocolic pouch, with no evidence of
alteration of intestinal loops. The day after, a diffuse maculo-
papular rash appeared with rosette-shaped lesions involving
the inferior limbs and the palms. Three days later, as fever was
still high (39°C) and abdominal pain worsened, repeated ab-
dominal CT scan was performed that showed wall stenosis and
concentric thickening in the jejunal loops, as well as small and
large intestine ectasia, ascitic effusion, and mesenteric lymph
node enlargement (Figure).
The main infectious causes were ruled out (serologic tests
for brucellosis, typhoid fever, rickettsiosis, measles; infection
because of cytomegalovirus, Epstein-Barr virus, mycoplasma,
leptospira; blood cultures, which were all negative).
The presence of maculopapular rash, conjunctival injec-
tion, high and persistent fever, changes in the peripheral
extremities and pharyngeal mucosa, and cervical lymphade-
nopathy suggested the diagnosis of Kawasaki disease with pos-
sible intestinal involvement. Echocardiogram was normal. IGIV
was administered (2 g/kg) with resolution of all symptoms
during the following 48 hours. Treatment with high-dose aspirin
also was started: 100 mg/kg/day for a total daily dose of 3 g,
which was decreased to 5 mg/kg/24 hours (200 mg/24 hours)
after stable disappearance of the fever. After approximately
2 weeks, desquamation of the toes and thrombocytosis
(498 000/uL) were detected and magnetic resonance imaging
showed complete resolution of the prior abdominal abnor-
malities. He was discharged and given salicylate therapy for 6
more weeks. An echocardiogram performed 6 months after dis-
charge showed no cardiac alterations.
Volume 202 • November 2018
187
Table I. Clinical and radiologic characteristics, therapy, and outcome of the reported patients with intestinal involvement in Kawasaki disease
First author Year
Country
Number of patients Age/sex Clinical onset
Intestinal involvement
(plain radiography or CT scan
or ultrasonography)
Cardiac or main arteries
involvement Surgery Outcome Therapy
Franken 19792
US
2 pts
3 y/F
1.5 y/M
Fever (2),
Vomiting (2)
Distended loops of small
bowel (2)
None (2) Laparotomy (1)
None (1)
Death (1)
Good (1)
None (2)
Mercer 19813
Canada
1 pt
NA Fever, abdominal pain Small bowel distension (1) Right coronary artery
arteritis (1)
Resection of necrotic
bowel (1)
Death (1) None
Fan 19864
China
1 pt
3 mo/M Abdomen distension, fissured lips,
conjunctival congestion, swollen
red extremities, rash
Multiple fluid levels, ischemic
colitis secondary to
pseudo-obstruction
Bilateral coronary artery
aneurysms
Enterolysis Good Aspirin
Miyake 19875
Japan
7 pts
NA Fever (3)
Vomiting (2)
Abdominal pain (1)
Abdominal distension (1)
NA (4)
Dilatation of bowel with
increased Volume of gas (3)
NA (4)
CAAs (5)
NA (2)
None (3)
NA (4)
Persistence of CAAs (3)
NA (4)
Aspirin + steroids (3)
NA (4)
Murphy 19876
US
1 pt
8 mo/M Fever, abdominal distension,
vomiting, rash, conjunctivitis,
pharyngitis, lymphadenopathy
Hydrops gallbladder, jejunal
obstruction
Aneurysms of left and
right subclavian arteries,
of coronary artery, of
brachiocephalic and
axillary arteries
Jejunal resection,
jejunojejunostomy
Good Aspirin dipyridamole
Wheeler 19907
UK
2 pts
16 mo/M
4 y/F
Fever, abdominal distension, and
bile-stained vomiting, rash,
cervical lymphadenopathy, and
conjunctivitis (2)
Distended bowel loops with
fluid levels (2)
None (2) None (2) Good (2) Intravenous fluids (1)
High-dose aspirin (1)
Huang 19908
Taiwan
1 pt
6 mo/M Fever, abdominal distension ,
jaundice, cervical
lymphadenopathy, conjunctival
congestion, fissured lips, rash
Dilatation of small bowel NA Laparotomy NA Aspirin
Mele 19969
Canada
1 pt
1 y/F Fever, vomiting, conjunctivitis, neck
stiffness
Incomplete midjejunal
obstruction.
Dilatation of the right and
left coronary arteries
Resection
jejunojejunostomy
NA IGIV
Aspirin
Chung 199610
US
1 pt
4 y/M Fever, abdominal pain, rash Isolated left colon mucosal
thickening
None Laparotomy Good IGIV
Aspirin
Chiba 199811
Japan
2 pts
6 y/M
4 y/M
Fever (2), abdominal pain (2),
vomiting (1), rash (2),
conjunctivitis (2), fissured lips (2)
Cecal ileus (2) None Appendectomy (2) Good IGIV (2)
Beiler 200112
Germany
1 pt
9 mo/F Fever, vomiting, diarrhea,
abdominal pain
Jejunal obstruction Pericardial effusion,
aneurysms of right and
left anterior descending
coronary
Resection obstructed
segment and
jejunojejunostomy
Good IGIV
Aspirin
Steroids
Fang 200113
Taiwan
1 pt
1 y/M Fever, fissured lips, vomiting,
abdominal distension
Intestinal pseudo-obstruction Coronary artery dilatation None NA IGIV
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Table I. Continued
First author Year
Country
Number of patients Age/sex Clinical onset
Intestinal involvement
(plain radiography or CT scan
or ultrasonography)
Cardiac or main arteries
involvement Surgery Outcome Therapy
Krohn 200114
Germany
1 pt
3 mo/F Fever, abdominal distension,
vomiting, gangrene of left
forehand and left forefoot
Jejunal obstruction Coronary artery aneurism Ileum resection
jejunostomy
Amputation of left hand
and forefoot
IGIV
Aspirin
Steroids
Zulian 200315
Italy
5 pts
2 pts: NA
1 pt: 5.4 y /M
1 pt: 5.1 y /M
1pt: 1.7 y/M
Fever (3)
Abdominal pain (3)
Diarrhea (1)
Hematemesis (1)
Rash (3), conjunctivitis (3)
NA: 2
Paralytic ileus (3)
Appendicitis (1)
Hemorrhagic duodenitis (1)
CAAs (1) Laparotomy (1)
Appendectomy (1)
Endoscopy(1)
Good (5) IGIV (5)
Akikusa 200416
Canada
1 pt
3.5 y/M Fever, vomiting, diarrhea, abdominal
pain, swollen red lips with some
mild, nonpurulent conjunctivitis,
rash
Air-filled loops of small bowel Right and left coronary
artery ectasia, aneurysm
of proximal right
coronary artery
None Persistent right
coronary artery
dilatation
IGIV
Aspirin
Thabet 200418
France
1 pt
5 y, F Fever, diarrhea, abdominal pain,
rash
Multiple dilated intestinal loops
with thickening of the wall
None None Death IGIV
Yaniv 200517
Israel
1 pt
8 mo/F Fever, diarrhea, bilious vomiting,
injected conjunctiva, red dry lips,
maculopapular rash involving the
trunk, and erythema of the throat.
Diffuse widening of intestinal
loops
None None Good IGIV
Aspirin
Pavone 200619
Italy
1 pt
18 mo/M Vomiting, abdominal distension,
scrotal swelling
Water and gas levels in ileum NA None NA IGIV
Tiao 200620
Taiwan
1 pt
2.5 y/M Fever, vomiting, abdominal pain,
peeling of the skin on fingers and
toes
Dilated bowel loops with
multiple air–fluid levels
Right and left coronary
artery dilatation
None Persistent right
coronary artery
dilatation
IGIV
Maurer 200821
Austria
2 pts
1 pt: 4 y/M
1 pt: 7 y/M
Fever (2), abdominal pain (2)
Vomiting (1)
Conjunctivitis (2)
Swollen red lips (1)
Pharyngitis (1)
Rash (2)
Lymphadenopathy (1)
Parietal stenosis and concentric
thickening of the duodenal
wall with pseudo-obstruction
at the third part of the
duodenum
(2)
Left coronary artery
dilatation (1)
None (1)
Appendectomy (1)
None (1)
Persistent coronary
artery dilatation (1)
Good (1)
IGIV
Aspirin (2)
Kim 200822
Korea
1 pt
5 y/M Fever, abdominal pain,
vomiting, erythema and swelling of
the hands and feet, and
strawberry tongue
Circumferential enhanced wall
thickening and edema in the
distal descending and
sigmoid colon
Pericardial effusion None Good IGIV
Aspirin
Lin 201023
Taiwan
1 pt
5 y/M Fever, abdominal pain, diarrhea, lips,
red eyes and a strawberry tongue
Multiple dilated intestinal loops Pericardial effusion Bowel decompression,
loop colostomy
Good Aspirin
Hussain 201024
UK
1 pt
3 y/M Fever, vomiting, abdominal pain,
jelly-like stools, rash
Intussusception NA None Good IGIV
Aspirin
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Table I. Continued
First author Year
Country
Number of patients Age/sex Clinical onset
Intestinal involvement
(plain radiography or CT scan
or ultrasonography)
Cardiac or main arteries
involvement Surgery Outcome Therapy
Miyamoto 201325
Japan
1 pt
5 y/M High fever, frequent diarrhea, and
abdominal pain
Ileus of the small bowel and
colonic mucosal thickening
Increased echo intensity in
the coronary arterial wall
and increased pericardial
effusion
Appendectomy Good IGIV
Miyahara 201326
Japan
1 pt
4 y M Fever and diarrhea, conjunctivitis,
rash, periungueal desquamation
Left colon mucosal thickening
consistent with acute colitis
None None Good IGIV
Aspirin
Garnett 201427
US
2 pts
1 pt: 3 y/M
1 pt: 7 y/F
Abdominal pain, nausea, vomiting,
diarrhea, and fever, (2)
Conjunctivitis (1)
Free fluid in the peritoneal
cavity (2)
Dilated loops of small bowel (1)
Appendicitis (2)
Dilatation of the coronary
arteries (2)
Appendectomy (2) Good (2) IGIV
Aspirin
Godart 201428
France
1 pt
7mo/NA Diarrhea, vomiting conjunctivitis Small-bowel occlusion with
superior mesenteric and
splenic ischemia associated
with abdominal effusion
Aneurysm with an origin
from both coronary
arteries and pericardial
effusion
Resections of the
small-bowel combined
with gastrostomy,
cholecystectomy, and
appendectomy
After 2 years complete
occlusion of the right
coronary artery
Warfarin
Masoumi 201529
Iran
1 pt
2.5 y/M Fever, melena, rash, conjunctivitis
erythematous lips, edema, and
erythema of palms and soles
X-ray: free subdiaphragmatic
intraperitoneal air
None Laparotomy: Perforated
ulcer was seen in
anterior portion of
descending duodenum
Good IGIV
Aspirin
Garcia Munitis 201530
Argentina
1 pt
4 y/M Fever, vomiting, diarrhea, abdominal
pain, conjunctival injection
Dilatation of small bowel and
mesenteric adenitis
None Laparotomy Good IGIV
Aspirin
Trapani 201631
Italy
1 pt
3 y/F Fever abdominal pain, conjunctivitis,
rash, hands and feet erythema,
and cheilitis
Dilated loops and multiple water
and gas levels in the ileum
Epi-pericardial effusion Appendectomy Good IGIV
Aspirin
Lone 201732
India
1 pt
2 y/M Fever, abdominal pain, bleeding per
rectum, cheilitis, and conjunctival
erythema
Air fluid levels suggestive of
intestinal obstruction
Coronary artery ectasia Ileostomy Good IGIV
Aspirin
Zhuang 201733
China
1 pt
1.7 y/F Fever, cough, rash, fissured lips,
bilateral conjunctivitis, edema
extremities, vomiting, diarrhea
Intestinal dilatation (fluid/gas
levels)
None None Good IGIV
Aspirin
Ohnishi 201734
Japan
1 pt
4 y M Fever, abdominal pain, rash,
swelling of both hands,
strawberry tongue conjunctival
hyperemia
Thickening of the wall localized
to the sigmoid colon
None None Good Aspirin
Present case 2018
Italy
1 pt
14 y/M Fever, abdominal pain, arthralgia,
lymphadenopathy conjunctival
hyperemia
Parietal stenosis and concentric
thickening in the jejunal
loops
None None Good IGIV
Aspirin
F, female; M, male; NA, not available; pt, patient.
Number in parentheses indicates the number of patients of each article reporting the characteristic of the column header.
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Discussion
The prevalence of gastrointestinal involvement in Kawasaki
disease is unknown as available data can only be derived from
single reports and few case series. Miyake et al in their retro-
spective case series of 310 children with Kawasaki disease
reported gastrointestinal involvement in only 7 cases (2.3%)5;
Zulian et al in their case series reported an incidence of
atypical Kawasaki disease with a clinical onset characterized
by acute surgical abdomen of 4.6%.15 Abdominal symptoms
in Kawasaki disease are more often due to hydrops of the
gallbladder.40,41 In Taiwan, a routine abdominal ultrasound
showed hydrops of the gallbladder in 21% of patients with
Kawasaki disease.42 The most often suggested underlying mecha-
nisms of hydrops are vasculitis and inflammation as well as
distal duct obstruction caused by lymph nodes. The latter also
may cause pancreatitis.43
In our review, we focused only on Kawasaki disease cases
involving the intestinal tract. Abdominal pain and vomiting
were the most frequently reported symptoms, followed by di-
arrhea. Gastrointestinal symptoms are relevant to a possible
diagnosis of Kawasaki disease when there are fewer than typical
diagnostic criteria for Kawasaki disease in the acute febrile
phase. In such cases, the onset of signs and symptoms also
may be dispersed over time as opposed to the close cluster-
ing of symptoms observed in the classical forms of Kawasaki
disease.
Accordingly, the clinical onset of Kawasaki disease with gas-
trointestinal involvement often leads to diagnostic and thera-
peutic delays—a risk factor for the development of coronary
complications.1
Despite efforts over 40 years, the etiology and pathophysi-
ology of Kawasaki disease are still unknown. It is generally
thought that Kawasaki disease results from a variety of infec-
tious agents that evoke an abnormal immunologic response
in genetically susceptible individuals. The results of immu-
nology, microbiology, and molecular studies suggest that
superantigen-producing agents may have a role in the etiology
of Kawasaki disease.44 The gastrointestinal tract has been pro-
posed as a major site of entry of infectious agents that might
act as superantigens, even though more recent studies have
favored a canonical response to a conventional antigen.1
Gastrointestinal involvement, therefore, may be due to the
vasculitis and thrombosis of small submucosal arteries involv-
ing the intestine; moreover, the profound small-bowel dilata-
tion detected in most patients is secondary to relative vascular
insufficiency.44-46
The effects of bowel ischemia are multiple, but initial
hypermotility followed by paralysis of the affected segment is
frequent. In most cases, circumferential bowel wall thicken-
ing is associated with the inflammatory changes and vasculi-
tis involving bowel vessels, in spite of the fact that the anatomic
obstruction is not documented. In our case, abdominal com-
plaints, as well as ultrasonography findings, promptly disap-
peared after initiation of therapy supporting the theory that
intestinal vasculitis may be responsible for the abdominal symp-
toms in Kawasaki disease.
Table II. Clinical features of 49 reported patients with Kawasaki disease with intestinal involvement
Symptoms Intestinal involvement Cardiac involvement Surgery Therapy Outcome
Fever 40/49 (82%)
Abdominal pain
34/49 (69%)
Vomiting 24/49 (49%)
Diarrhea 14/49 (29%)
Jaundice 1/49(2%)
Pseudo-obstruction
32/49 (65%)
Pseudo-obstruction + idrope of
gallbladder 1/49 (2%)
Pseudo-obstruction + ischemic
colitis 1/49 (2%)
Pseudo-obstruction +
hemorrhagic duodenitis
1/49 (2%)
Pseudo-obstruction with
mesenteric and splenic
ischemia 1/49 (2%)
Pseudo-obstruction +
appendicitis 2/49 (4%)
Intussusception 1/49 (2%)
Hemorrhagic duodenitis
1/49 (2%)
Appendicitis 8/49 (16%)
None 18/49 (37%)
Pericardial effusion
3/49(6%)
CAAs 21/49 (43%)
NA: 12/49 (24%)
None 19/49 (39%)
Resection + ostomy
8/49 (16%)
Enterolisis 1/49 (2%)
Cholecystectomy 1/49 (2%)
Explorative laparotomy
5/49 (10%)
Appendectomy 10/49 (20%)
Minor invasive procedures
1/49 (2%)
NA: 4/49 (8%)
Aspirin 4/49 (8%)
Aspirin + dipyridamole
1/49 (2%)
IGIV 12/49 (24%)
Aspirin + steroid 3/49 (6%)
Aspirin + IGIV 18/49 (37%)
Warfarin 1/49 (2%)
None 5/49 (10%)
NA: 4/49 (8%)
Good 28/49 (57%)
Persistence CAAs 7/49
(14%)
Sequelae (amputation)
1/49(2%)
Recurrence Kawasaki
disease 1/49(2%)
Death 3/49 (6%)
NA: 4/49 (8%)
Figure. Abdominal CT of the present case showing wall ste-
nosis and concentric thickening in the jejunal loops (arrows).
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More severe cases might produce nodular areas or cause ob-
struction that can lead to surgical treatments.21,22 The high
incidence of CAAs observed in Kawasaki disease with gastro-
intestinal involvement should prompt the physician to search
for the presence of coronary aneurysms. Indeed, in most re-
ported cases, Kawasaki disease was diagnosed after at least an
explorative laparotomy had been performed. However, we can
assume that medical treatment is fundamental to avoid a
further clinical progression of the mesenteric vasculitis;
therefore, conservative management of such patients as for
Kawasaki disease,1,47 with high-dose IGIV plus aspirin, seems
to be appropriate.
The diagnosis of Kawasaki disease should be considered
in all children with fever, abdominal pain, and radiologic
signs of pseudo-obstruction, even in the absence of typical
symptoms and signs. A more comprehensive analysis
including all clinical forms of Kawasaki disease would be
useful to correlate intestinal involvement with worse out-
comes for cardiac complications, as well as to clues to more
rapid diagnosis and avoidance of unnecessary invasive
procedures. ■
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50 Years Ago in The Journal of Pediatrics
Use of the Telephone by Low-Income Families
Heagarty MC, Robertson L, Kosa J, Alpert JJ. J Pediatr 1968;73:740-4
T he first sentence of the study by Heagarty et al reads “particularly for pediatricians, the telephone represents anessential, if at times exasperating part of practice.” It made me smile. Maybe technology has changed the world
in the past 50 years, but we have not changed as much. Phone calls are still exasperating from time to time.
The study describes a program in which low-income families had 24/7 access to medical care via a telephone an-
swering service. During 2 months in 1965 and another 2 months in 1967, the authors analyzed when and why pa-
tients called, how the doctor perceived them, and how it was resolved. The number of phone calls increased in those
2 years. Calls were more frequent during the day and during the week, not weekends. They called because of a fever, a
respiratory illness, an accident, or a rash, but usually, parents wanted advice and not necessarily to see the doctor. And
doctors overestimated the mother’s anxiety when the reason for calling was that, indeed, the condition of a child had
changed or deteriorated. All of this may resemble current practice.
The difference now is the variety of gadgets (telephones, mobile devices, personal computers) and platforms (texting
services, social media, electronic health records) that allow us to communicate with our patients. This may differ de-
pending on where you practice. The Health Insurance Portability and Accountability Act of 1996, for example, is much
more stringent than laws in other countries. Personally, I engage and communicate with patients using Facebook and
WhatsApp, which may seem unfathomable for pediatricians in the US. And not only patients reach us using technol-
ogy, we too reach to them. We use communication technology to send reminders for healthcare appointments, to send
results of tests, to promote good health behaviors (eg, to help quit smoking or to reduce risky sexual practices in pa-
tients with HIV) and adherence to medication, to increase vaccination rates, or to coordinate management of chronic
conditions such as asthma.
But, in the end, nothing replaces a good old fashioned face-to-face patient–doctor encounter. At least, not in the
next 50 years.
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